Adjuvant toripalimab or combined with S-1 in recurrent, previously irradiated head and neck squamous cell carcinoma treated with salvage surgery: A phase II clinical trial (The RePASS study). This is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback